Analysen zu Novo Nordisk
| 22.04.25 | Novo Nordisk Buy | UBS AG | |
| 22.04.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 22.04.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 17.04.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 17.04.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 17.04.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 16.04.25 | Novo Nordisk Overweight | Barclays Capital | |
| 08.04.25 | Novo Nordisk Buy | UBS AG | |
| 07.04.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 07.04.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 07.04.25 | Novo Nordisk Buy | UBS AG | |
| 04.04.25 | Novo Nordisk Buy | UBS AG | |
| 03.04.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 03.04.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 03.04.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 31.03.25 | Novo Nordisk Buy | UBS AG | |
| 28.03.25 | Novo Nordisk Buy | UBS AG | |
| 28.03.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 28.03.25 | Novo Nordisk Buy | UBS AG | |
| 24.03.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 24.03.25 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 21.03.25 | Novo Nordisk Buy | UBS AG | |
| 17.03.25 | Novo Nordisk Buy | UBS AG | |
| 14.03.25 | Novo Nordisk Buy | UBS AG | |
| 12.03.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 11.03.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 11.03.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 11.03.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 10.03.25 | Novo Nordisk Buy | UBS AG | |
| 10.03.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 10.03.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 10.03.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 07.03.25 | Novo Nordisk Buy | UBS AG | |
| 04.03.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 03.03.25 | Novo Nordisk Buy | UBS AG | |
| 26.02.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 25.02.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 24.02.25 | Novo Nordisk Buy | UBS AG | |
| 20.02.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 19.02.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 17.02.25 | Novo Nordisk Buy | UBS AG | |
| 17.02.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 12.02.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 11.02.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 11.02.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 10.02.25 | Novo Nordisk Buy | UBS AG | |
| 10.02.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 10.02.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 07.02.25 | Novo Nordisk Buy | UBS AG | |
| 06.02.25 | Novo Nordisk Halten | DZ BANK |
Aktuelle Aktienanalysen
| 11.03.26 | Porsche vz. Sector Perform | RBC Capital Markets | |
| 11.03.26 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 11.03.26 | WACKER CHEMIE Hold | Jefferies & Company Inc. | |
| 11.03.26 | Rheinmetall Overweight | JP Morgan Chase & Co. | |
| 11.03.26 | Renault Outperform | Bernstein Research | |
| 11.03.26 | Henkel vz. Hold | Jefferies & Company Inc. | |
| 11.03.26 | Porsche vz. Hold | Jefferies & Company Inc. | |
| 11.03.26 | Porsche vz. Market-Perform | Bernstein Research | |
| 11.03.26 | SAP Buy | UBS AG | |
| 11.03.26 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 11.03.26 | Symrise Overweight | JP Morgan Chase & Co. | |
| 11.03.26 | BBVA Overweight | JP Morgan Chase & Co. | |
| 11.03.26 | Porsche vz. Overweight | JP Morgan Chase & Co. | |
| 11.03.26 | Vestas Wind Systems A-S Overweight | JP Morgan Chase & Co. | |
| 11.03.26 | AIXTRON Overweight | JP Morgan Chase & Co. | |
| 11.03.26 | Volkswagen Overweight | Barclays Capital | |
| 11.03.26 | Oracle Overweight | Barclays Capital | |
| 11.03.26 | Microsoft Outperform | RBC Capital Markets | |
| 11.03.26 | Siemens Healthineers Overweight | Barclays Capital | |
| 11.03.26 | STRATEC Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 11.03.26 | Nike Overweight | Barclays Capital | |
| 11.03.26 | Volkswagen Market-Perform | Bernstein Research | |
| 11.03.26 | Oracle Buy | Goldman Sachs Group Inc. | |
| 11.03.26 | Nordex Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 11.03.26 | Carl Zeiss Meditec Neutral | UBS AG | |
| 11.03.26 | Oracle Buy | Jefferies & Company Inc. | |
| 10.03.26 | BioNTech Buy | Jefferies & Company Inc. | |
| 10.03.26 | TRATON Hold | Jefferies & Company Inc. | |
| 10.03.26 | Commerzbank Sector Perform | RBC Capital Markets | |
| 10.03.26 | Pfizer Neutral | UBS AG | |
| 10.03.26 | Boeing Outperform | RBC Capital Markets | |
| 10.03.26 | Deutsche Beteiligungs Buy | Baader Bank | |
| 10.03.26 | Stellantis Kaufen | DZ BANK | |
| 10.03.26 | Swiss Re Neutral | JP Morgan Chase & Co. | |
| 10.03.26 | HUGO BOSS Neutral | JP Morgan Chase & Co. | |
| 10.03.26 | BioNTech Buy | Deutsche Bank AG | |
| 10.03.26 | FedEx Neutral | JP Morgan Chase & Co. | |
| 10.03.26 | London Stock Exchange Buy | Deutsche Bank AG | |
| 10.03.26 | Deutsche Börse Buy | Deutsche Bank AG | |
| 10.03.26 | Roche Hold | Deutsche Bank AG | |
| 10.03.26 | Airbus Buy | Deutsche Bank AG | |
| 10.03.26 | STMicroelectronics Buy | Deutsche Bank AG | |
| 10.03.26 | Symrise Overweight | JP Morgan Chase & Co. | |
| 10.03.26 | Deutsche Börse Overweight | JP Morgan Chase & Co. | |
| 10.03.26 | Ströer Overweight | JP Morgan Chase & Co. | |
| 10.03.26 | London Stock Exchange Overweight | JP Morgan Chase & Co. | |
| 10.03.26 | VINCI Overweight | Barclays Capital | |
| 10.03.26 | Volvo AB Market-Perform | Bernstein Research | |
| 10.03.26 | TRATON Market-Perform | Bernstein Research | |
| 10.03.26 | Daimler Truck Underperform | Bernstein Research |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.